Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other...

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. Extraordinary persistence, grit, and unwavering passion drive our commitment to the delivery of scientific innovation.

2025年3月3日 · Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it will implement a 1-for-15 reverse stock split of...

3 天之前 · Shares of Karyopharm Therapeutics Inc. soared 65% in trading on Monday after the drugmaker said an experimental combination treatment for multiple myeloma met its primary endpoint in a late-stage...

2025年3月5日 · Get a real-time Karyopharm Therapeutics Inc. (KPTI) stock price quote with breaking news, financials, statistics, charts and more.

简介：Karyopharm Therapeutics Inc.于2008年12月22日在特拉华州注册成立。 该公司是一家临床阶段的制药公司，专注于发现和开发针对核转运靶点的新型一线药物，用于治疗癌症和重大疾病。 该公司的科学专长集中在了解细胞核和细胞质之间细胞内运输的调节。 该公司发现并开发了抑制核输出蛋白XPO1的全资、新型、小分子、核输出选择性抑制剂或SINE化合物。 该公司的主要候选药物Selinexor（KPT-330）是一种XPO1抑制剂，正在多个开放标签的1期临床试验中接受评 …

Discover real-time Karyopharm Therapeutics Inc. Common Stock (KPTI) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with...

2025年3月8日 · Stock analysis for Karyopharm Therapeutics Inc (KPTI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

View the latest Karyopharm Therapeutics Inc. (KPTI) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Get real-time updates on Karyopharm Therapeutics Inc. Common Stock (KPTI) stock quotes, trades, and more. Make informed investments with Nasdaq.